Despite an increased awareness and ‘normalization’ of Human Papillomavirus (HPV) following the release of the HPV vaccine, the psychosocial impact of an HPV infection, the most common sexually transmissible infection (STI), must not be overshadowed. This study employed in-depth interviews (N = 52) and quantitative surveys (N = 154) to assess the knowledge, emotional impact and behavioral consequences of an HPV-related diagnosis in women who had received abnormal Pap test results. Findings revealed confusion over test results and themes related to stigma, fear, self-blame, powerlessness and anger emerged. The promotion of the HPV vaccine should not obfuscate the psychosocial burden associated with an HPV diagnosis.
Anhang, R., Wright, T.C., Smock, L., & Goldie, S.J. ( 2003). Women’s desired information about Human Papillomavirus . Cancer, 100, 315-320.
2.
Brown, D.R., Kjaer, S.K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C.M. et al. (2009). The impact of quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. Journal of Infectious Diseases, 199, 926-935.
3.
Centers for Disease Control and Prevention (CDC). ( 2007). Advisory Committee on Immunization Practices. http://www.cdc.gov/vaccines/recs/ACIP/downloads/min-oct07.pdf (accessed 4 September 2008).
4.
Centers for Disease Control and Prevention (CDC). ( 2008a). Genital HPV infection: CDC fact sheet. http://www.cdc.gov/std/HPV/STDFactHPV.htm (accessed 28 December 2008).
5.
Centers for Disease Control and Prevention (CDC). ( 2008b). HPV vaccine information for young women. http://www.cdc.gov/std/hpv/STDFact-HPV-vaccine.htm (accessed 4 September 2008).
6.
Charo, R.A. ( 2007). Politics, parents, and prophylaxis: Mandating HPV vaccination in the United States. New England Journal of Medicine, 356, 1905-1908.
7.
Daley, E.M., Perrin, K.M., Vamos, C., Webb, C., Mueller, T., Packing-Ebuen, J.L. et al. (2008). HPV knowledge among HPV+ women. American Journal of Health Behavior, 32, 477-487.
8.
Denny-Smith, T., Bairan, A., & Page, M.C. ( 2006). A survey of female nursing students’ knowledge, health beliefs, perceptions of risk, and risk behaviors regarding Human Papillomavirus and cervical cancer. Journal of the America Academy of Nurse Practitioners, 18, 62-69.
9.
Food and Drug Administration (FDA). (2006). GARDASIL® Questions and answers. http://www.fda.gov/cber/products/hpvmer060806qa.htm (accessed 5 May 2009).
10.
Gerhardt, C.A., Pong, K., Kollar, L.M., Hillard, P.J.A., & Rosenthal, S.L. (2000). Adolescents’ knowledge of Human Papillomavirus and cervical dysplasia. Journal of Pediatric and Adolescent Gynecology, 13, 15-20.
11.
Gravitt, P.E., & Shah, K.V. ( 2005). A virus-based vaccine may prevent cervical cancer . Current Infectious Disease Reports, 7, 125-131.
12.
Holcomb, B., Bailey, J.M., Crawford, K., & Ruffin, M.T. ( 2004). Adults’ knowledge and behaviors related to Human Papillomavirus infection. Journal of the American Board of Family Practitioners, 17, 26-31.
13.
Kahn, J.A., Slap, G.B., Bernstein, D.I., Kollar, L.M., Tissor, M., Hillard, P.A. et al. (2005). Psychological, behavioral, and interpersonal impact of Human Papillomavirus and Pap test results. Journal of Women’s's Health, 14, 650-659.
14.
Maissi, E., Marteau, T.M., Hankins, M., Moss, S., Legood, R., & Gray, A. ( 2004). Psychological impact of Human Papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: Cross sectional questionnaire study. British Medical Journal , 328, 1293-1296.
15.
Massad, L.S., Verhulst, S.J., Hagemeyer, M., & Brady, P. ( 2006). Knowledge of the cervical cancer screening process among rural and urban Illinois women undergoing colposcopy. Journal of the Lower Genital Tract Disease, 10, 252-255.
16.
McCaffery, K., Waller, J., Nazroo, J., & Wardle, J. ( 2006). Social and psychological impact of HPV in cervical screening: A qualitative study. Sexually Transmitted Infectections , 82, 169-174.
17.
Merck & Co., Inc. (2007). A randomized, international, double-blinded (with in-house blinding), controlled with Gardasil®, dose-ranging, tolerability, immunogenicity, and efficacy study of a multivalent Human Papillomavirus (HPV) L1 virus-like particle (VLP) vaccine administered to 16- to 26-year-old women. http://www.clinicaltrials.gov/ct2/show/NCT00543543?term=Broad+Spectrum+HPV+%28Human+Papillomavirus%29+Vaccine+Study+in+16-to+26-Year-Old+Women&rank=1 (accessed 4 September 2008 ).
18.
Perrin, K., Daley, E., Naoom,S., Packing-Ebuen, J., Rayko, H., McFarlane, M. et al. (2006). Women’s reactions to HPV diagnosis: Insights from in-depth interviews. Women & Health, 43, 93-110.
19.
Rogstad, K.E. ( 2002). The psychological impact of abnormal cytology and colposcopy . British Journal of Obstetrics and Gynaecology , 109, 364-368.
20.
Rubin, R. ( 2007). Vaccines: Mandates or choice?http://www.usatoday.com/news/health/2007-02-07-vaccines_x.htm (accessed 4 September 2008).
21.
Summers, A. ( 1998). Mental health consequences of cervical screening . Psychology, Health & Medicine, 3, 113-126.
22.
Tiro, J.A., Meissner, H.I., Korbin, S., & Chollette, V. ( 2007). What do women in the U.S. know about Human Papillomavirus and cervical cancer? Cancer Epidemiology Biomarkers & Prevention, 16, 288-294.
23.
Vamos, C.A., McDermott, R.J., & Daley, E.M. ( 2008). The HPV vaccine: Framing the arguments FOR and AGAINST mandatory vaccination of all middle school girls. Journal of School Health, 78, 302-309.
24.
Waller, J., McCaffery, K., Kitchener, H., Nazroo, J., & Wardle, J. ( 2007). Women’s experiences of repeated HPV testing in the context of cervical cancer screening: A qualitative study. Psychooncology, 16, 196-204.
25.
Wheeler, C.M., Kjaer, S.K., Sigurdsson, K., Iversen, O.E., Hernandez-Avila, M., Perez, G. et al. (2009). The impact of quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. Journal of Infectious Diseases, 199, 936-944.
26.
Yacobi, E., Teenant, C., Ferrante, J., Pal, N., & Roetzheim, R. ( 1999). University students’ knowledge and awareness of HPV. Preventive Medicine, 28, 535-541.
